{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:03:21Z","timestamp":1785452601094,"version":"3.56.0"},"reference-count":65,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T00:00:00Z","timestamp":1627171200000},"content-version":"unspecified","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Department of Veterans Affairs Health Services Research & Development","award":["1I01HX002917-01A1"],"award-info":[{"award-number":["1I01HX002917-01A1"]}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"crossref","award":["R01DK101500"],"award-info":[{"award-number":["R01DK101500"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Center for Innovations in Quality","award":["CIN 13-413"],"award-info":[{"award-number":["CIN 13-413"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2021,7,4]]},"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:p>The management of patients with type 2 diabetes and chronic kidney disease (CKD) encompasses lifestyle modifications, glycemic control with individualized HbA1c targets, and cardiovascular disease risk reduction. Metformin and sodium-glucose cotransporter-2 inhibitors are first-line agents. Glucagon-like peptide-1 receptor agonists are second-line agents. The use of other antidiabetic agents should consider patient preferences, comorbidities, drug costs, and the risk of hypoglycemia. Renin\u2013angiotensin\u2013aldosterone system inhibitors are strongly recommended for patients with diabetes, hypertension, and albuminuria. Non-steroidal mineralocorticoid receptor antagonists, which pose less risk of hyperkalemia than steroidal agents, are undergoing further evaluation among patients with diabetic kidney disease. Here, we discuss important advancements in the management of patients with type 2 diabetes and CKD.<\/jats:p>","DOI":"10.1136\/bmjdrc-2021-002300","type":"journal-article","created":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T16:41:04Z","timestamp":1627317664000},"page":"e002300","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":37,"title":["Management of type 2 diabetes in chronic kidney disease"],"prefix":"10.1136","volume":"9","clinical-trial-number":[{"clinical-trial-number":"nct03819153","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02545049","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3607-6838","authenticated-orcid":false,"given":"Jefferson L","family":"Triozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Parker Gregg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim S","family":"Virani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4953-7795","authenticated-orcid":false,"given":"Sankar D","family":"Navaneethan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,7,26]]},"reference":[{"key":"2024101822454069000_9.1.e002300.1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the global burden of disease study 2017","volume":"395","author":"Bikbov","year":"2020","journal-title":"The Lancet"},{"key":"2024101822454069000_9.1.e002300.2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2008121270"},{"key":"2024101822454069000_9.1.e002300.3","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00580111"},{"key":"2024101822454069000_9.1.e002300.4","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(15)00094-7"},{"key":"2024101822454069000_9.1.e002300.5","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw070"},{"key":"2024101822454069000_9.1.e002300.6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.861"},{"key":"2024101822454069000_9.1.e002300.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1310799"},{"key":"2024101822454069000_9.1.e002300.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2009.10.007"},{"key":"2024101822454069000_9.1.e002300.9","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2015.173"},{"key":"2024101822454069000_9.1.e002300.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.06.019"},{"key":"2024101822454069000_9.1.e002300.11","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-S011"},{"key":"2024101822454069000_9.1.e002300.12","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2012.3617"},{"key":"2024101822454069000_9.1.e002300.13","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2014.192"},{"key":"2024101822454069000_9.1.e002300.14","doi-asserted-by":"publisher","DOI":"10.1097\/MCO.0000000000000342"},{"key":"2024101822454069000_9.1.e002300.15","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-0545"},{"key":"2024101822454069000_9.1.e002300.16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/7489795","article-title":"Association of glycemic indices (hyperglycemia, glucose variability, and hypoglycemia) with oxidative stress and diabetic complications","volume":"2020","author":"Papachristoforou","year":"2020","journal-title":"J Diabetes Res"},{"key":"2024101822454069000_9.1.e002300.17","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-0915"},{"key":"2024101822454069000_9.1.e002300.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052187"},{"key":"2024101822454069000_9.1.e002300.19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1111732"},{"key":"2024101822454069000_9.1.e002300.20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2008.02496.x"},{"key":"2024101822454069000_9.1.e002300.21","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-2322"},{"key":"2024101822454069000_9.1.e002300.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.11.023"},{"key":"2024101822454069000_9.1.e002300.23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802743"},{"key":"2024101822454069000_9.1.e002300.24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806470"},{"key":"2024101822454069000_9.1.e002300.25","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.132"},{"key":"2024101822454069000_9.1.e002300.26","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-0936"},{"key":"2024101822454069000_9.1.e002300.27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.13206"},{"key":"2024101822454069000_9.1.e002300.28","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.409"},{"key":"2024101822454069000_9.1.e002300.29","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.0292"},{"key":"2024101822454069000_9.1.e002300.30","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-2391"},{"key":"2024101822454069000_9.1.e002300.31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001076","article-title":"Effectiveness and safety of metformin in 51\u2008675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish national diabetes register","volume":"2","author":"Ekstr\u00f6m","year":"2012","journal-title":"BMJ Open"},{"key":"2024101822454069000_9.1.e002300.32","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.10180916"},{"key":"2024101822454069000_9.1.e002300.33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1515920"},{"key":"2024101822454069000_9.1.e002300.34","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14158"},{"key":"2024101822454069000_9.1.e002300.35","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611925"},{"key":"2024101822454069000_9.1.e002300.36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812389"},{"key":"2024101822454069000_9.1.e002300.37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1811744"},{"key":"2024101822454069000_9.1.e002300.38","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfy090"},{"key":"2024101822454069000_9.1.e002300.39","doi-asserted-by":"crossref","first-page":"l1328","DOI":"10.1136\/bmj.l1328","article-title":"Efficacy and safety of dual SGLT 1\/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials","volume":"60","author":"Musso","year":"2019","journal-title":"BMJ"},{"key":"2024101822454069000_9.1.e002300.40","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz258"},{"key":"2024101822454069000_9.1.e002300.41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA2030186"},{"key":"2024101822454069000_9.1.e002300.42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2030183"},{"key":"2024101822454069000_9.1.e002300.43","doi-asserted-by":"crossref","unstructured":"Liu J , Li L , Li S , et al . Effects of SGLT2 inhibitors on UTIs and genital infections in type 2 diabetes mellitus: a systematic review and meta-analysis. Sci Rep 2017;7.doi:10.1038\/s41598-017-02733-w","DOI":"10.1038\/s41598-017-02733-w"},{"key":"2024101822454069000_9.1.e002300.44","doi-asserted-by":"publisher","DOI":"10.7326\/M19-0085"},{"key":"2024101822454069000_9.1.e002300.45","doi-asserted-by":"publisher","DOI":"10.2337\/db15-1356"},{"key":"2024101822454069000_9.1.e002300.46","article-title":"Euglycemic ketoacidosis as a complication of SGLT2 inhibitor therapy","volume":"17621120","author":"Palmer","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"2024101822454069000_9.1.e002300.47","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1701990"},{"key":"2024101822454069000_9.1.e002300.48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002983"},{"key":"2024101822454069000_9.1.e002300.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2016.09.001"},{"key":"2024101822454069000_9.1.e002300.50","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.236"},{"key":"2024101822454069000_9.1.e002300.51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1616011"},{"key":"2024101822454069000_9.1.e002300.52","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607141"},{"key":"2024101822454069000_9.1.e002300.53","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1901118"},{"key":"2024101822454069000_9.1.e002300.54","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30104-9"},{"key":"2024101822454069000_9.1.e002300.55","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"The Lancet"},{"key":"2024101822454069000_9.1.e002300.56","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.038868"},{"key":"2024101822454069000_9.1.e002300.57","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.120.051783"},{"key":"2024101822454069000_9.1.e002300.58","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.10260"},{"key":"2024101822454069000_9.1.e002300.59","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-1350"},{"key":"2024101822454069000_9.1.e002300.60","doi-asserted-by":"publisher","DOI":"10.1111\/j.0894-0959.2004.17346.x"},{"key":"2024101822454069000_9.1.e002300.61","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01290-3"},{"key":"2024101822454069000_9.1.e002300.62","doi-asserted-by":"crossref","unstructured":"Currie G , Taylor AHM , Fujita T , et al . Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis. BMC Nephrol 2016;17.doi:10.1186\/s12882-016-0337-0","DOI":"10.1186\/s12882-016-0337-0"},{"key":"2024101822454069000_9.1.e002300.63","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa736"},{"key":"2024101822454069000_9.1.e002300.64","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.10081"},{"key":"2024101822454069000_9.1.e002300.65","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2025845"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2021-002300","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T07:38:28Z","timestamp":1729582708000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2021-002300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,7,26]]},"published-print":{"date-parts":[[2021,7]]}},"alternative-id":["10.1136\/bmjdrc-2021-002300"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2021-002300","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}